Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simethicone Premedication for Gastroscopy Visibility
NCT02555228Phase 3Completed
- Sponsor
- Changi General Hospital
- Start
- Aug 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of simethicone, sponsored by Changi General Hospital. Started Aug 2015; status: completed.
02
Drugs
simethicone
Beyond the preview
Go deeper on NCT02555228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555228.